The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2019
Filed:
Jun. 25, 2015
Applicant:
The General Hospital Corporation, Boston, MA (US);
Inventors:
Randall T. Peterson, Salt Lake City, UT (US);
Andrew J. Rennekamp, Boston, MA (US);
David Kokel, Berkeley, CA (US);
You Wang, Nanjing, CN;
Assignee:
The General Hospital Corporation, Boston, MA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 487/10 (2006.01); C07D 215/12 (2006.01); C07D 295/15 (2006.01); C07D 295/192 (2006.01); C07D 307/81 (2006.01); A61K 49/00 (2006.01); C07D 295/155 (2006.01);
U.S. Cl.
CPC ...
C07D 487/10 (2013.01); A61K 49/0008 (2013.01); C07D 215/12 (2013.01); C07D 295/15 (2013.01); C07D 295/155 (2013.01); C07D 295/192 (2013.01); C07D 307/81 (2013.01);
Abstract
The invention described herein relates generally to neuroactive compounds and compositions for the treatment psychotic disorders, methods for treating psychosis using these neuroactive compounds, and methods for screening for novel neuroactive compounds. Certain aspects are directed to a family of compounds called 'finazines.' Certain aspects are directed to in vivo screening methods using high-through-put behavioral assays in zebrafish.